Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
about
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideAmerican Cancer Society Head and Neck Cancer Survivorship Care GuidelineWhole-Body Vibration as a Modality for the Rehabilitation of Peripheral Neuropathies: Implications for Cancer Survivors Suffering from Chemotherapy-Induced Peripheral NeuropathyAmerican Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCalcium and Magnesium for Oxaliplatin-Induced Neurotoxicity: Issues in Study Design, Measurement, and AnalysisChemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveCancer-treatment-induced neurotoxicity--focus on newer treatmentsAmerican Cancer Society Colorectal Cancer Survivorship Care GuidelinesAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsVincristine-induced peripheral neuropathy in pediatric cancer patientsAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsLong term side effects of adjuvant chemotherapy in patients with early breast cancerPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewCoadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptorsExenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in RatsClinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateClinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancerSymptom management in the older adult: 2015 updateProgressive muscle relaxation combined with Chinese medicine five-element music on depression for cancer patients: A randomized controlled trial.Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.Effects of transcutaneous electrical nerve stimulation on chemotherapy-induced peripheral neuropathy symptoms (CIPN): a preliminary case-control study.Analysis of Risk Factors of Peripherally Inserted Central Catheter Induced Catheter-related Infection in Patients with Leukemia.Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathyRandomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Analgesic effects of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L.) Gaertn in paclitaxel-induced neuropathic pain in ratsBrain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity.Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathyCancer survivorship issues: life after treatment and implications for an aging populationTherapeutic strategies for cancer treatment related peripheral neuropathies.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Herbal medicines for the treatment of cancer chemotherapy-induced side effects.Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.Platinum-induced neurotoxicity and preventive strategies: past, present, and future
P2860
Q24289538-687BDEA6-3901-4FE5-A9E0-C085F7362B09Q26749476-923AF5C2-677C-4C57-9A0B-9B5E313E9902Q26752802-6566502F-F6D0-4806-8B6A-AD9AD81C8CB9Q26771423-8D17FFEE-AC78-4DA6-B291-7D34FBD038ABQ26773986-0DB5F338-5091-4168-94F4-7220CA317D95Q26777879-C8C67257-AF2B-4B08-8DA6-92BACDBFE757Q26777967-65264406-C1E9-4364-B6C1-C657CB314948Q26782604-C3FDE508-9B78-43E2-A21D-8E847DCC790DQ26782671-89B9239D-CF74-4299-87A0-DBEAE4174762Q27305830-651252C5-BBEA-4052-B645-50086EBDF019Q27314983-B7B8921E-2A33-4BF9-86FE-8202433C6B8FQ28078232-BFCC31AF-2BBA-4E6B-B5F2-24AE117EC289Q28079708-5BB9B398-4BCB-4BA5-8E56-66354DC1FB23Q28083233-5047DC1D-C152-48DF-9CB6-4265745058FAQ28085455-A04E8250-9C15-405E-B83B-795B0C48EB88Q28270819-11E9E346-0265-4736-B93F-421E1370CC47Q28315016-21255EDD-E76F-429D-8DDD-8E547E125E19Q28550675-B732E4B7-B12F-43F1-98D5-F04C7486FC33Q30234688-EAA35B81-8D84-44AA-B37A-984E35F9B8E6Q30234847-D21285DB-0B78-4EF9-8078-9368A9DEC324Q30356434-D3DD0F09-4619-437D-A7BA-F65D73721996Q30372504-17A77EF1-48A4-4A26-980A-B632545305EDQ30374202-9133AD21-F653-47E1-A4BE-C76D7B6D4BB5Q30401901-D421730A-47EA-4EB5-9DC6-2E15A1108C78Q30491771-810C29C8-E326-430C-A264-A561DC815E24Q33672384-51310C01-AE1F-4886-84EC-379D30495E73Q33680116-20BBC7B3-158D-4F95-99E5-0A3520A44F7CQ33711065-4242511B-4D40-446B-90A2-945850E1FC83Q33711656-B6F22063-EEA5-41E0-9828-72E8ED7F3B8EQ33796889-19E1A797-B260-4BB9-AA02-14CCA0974E92Q33824948-EE5EE7D9-636F-4C51-B593-ADBA8FF8CED8Q33837092-37EE3972-65E9-4D6F-B415-AE89A9253CAFQ33842874-1B60F03C-3672-47B9-9420-1D50B703231CQ34133825-BEABD18E-F7F3-4934-8C5B-D8FB1D6C6DF4Q34185068-13975935-300A-4A99-8991-50A0863DD717Q34433406-EE1D0F3A-65C1-4371-BD5E-EDF23BC65E98Q34765028-2B5E7104-2857-4633-8ABE-00E2957B2070Q35066654-8127E761-3253-45A7-BDD3-5980976683FDQ35331858-D0A0BBED-9A3F-4D6C-AB02-13311EB1C2E6Q35345734-71FD009E-C6B6-48F4-B223-03782C47DD1C
P2860
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prevention and management of c ...... y clinical practice guideline.
@ast
Prevention and management of c ...... y clinical practice guideline.
@en
Prevention and management of c ...... y clinical practice guideline.
@nl
type
label
Prevention and management of c ...... y clinical practice guideline.
@ast
Prevention and management of c ...... y clinical practice guideline.
@en
Prevention and management of c ...... y clinical practice guideline.
@nl
prefLabel
Prevention and management of c ...... y clinical practice guideline.
@ast
Prevention and management of c ...... y clinical practice guideline.
@en
Prevention and management of c ...... y clinical practice guideline.
@nl
P2093
P50
P356
P1476
Prevention and management of c ...... y clinical practice guideline.
@en
P2093
Antoinette Lavino
Bryan Schneider
Charles L Loprinzi
Christina Lacchetti
Cynthia Chauhan
Dawn L Hershman
Ellen M Lavoie Smith
Jonathan Bleeker
Mary Lou Smith
P304
P356
10.1200/JCO.2013.54.0914
P407
P577
2014-04-14T00:00:00Z